New hope for hard-to-treat leukemia: experimental combo enters human testing
Disease control
Recruiting now
This early-phase study tests a new two-drug combination (bomedemstat plus venetoclax) in 18 adults whose acute myeloid leukemia (AML) has returned or not responded to standard therapy. The main goal is to find a safe dose and understand side effects. Researchers will also check i…
Phase: PHASE1 • Sponsor: Terrence J Bradley, MD • Aim: Disease control
Last updated May 06, 2026 16:01 UTC